Blog

30 Dec 2022

HilleVax, Boston’s biggest IPO of 2022, wants to end common norovirus effect

29 Dec 2022

Congressional investigation reveals ‘atypical,’ ‘inappropriate...

29 Dec 2022

MassDevelopment’s biggest funding recipients in 2022

29 Dec 2022

Boston sees its first new major lab proposal in months

29 Dec 2022

Southwest expects to resume Friday schedule with ‘minimal disruptions̵...

29 Dec 2022

Healey team taps Paige Scott Reed of Prince Lobel Tye for chief legal counsel

29 Dec 2022

Editorial: FDA, don’t bog down cranberry sales

29 Dec 2022

Here are the Massachusetts companies that raised the largest Series A rounds in...

29 Dec 2022

The Largest IPOs in Massachusetts of 2022

29 Dec 2022

The Petri Dish: Group eyes Biogen Alzheimer’s drug price, FDA rejects psyc...

29 Dec 2022

Biotechs and VCs 2022: Top life sciences deals of the past year

29 Dec 2022

Pay was a big challenge in 2022. It’s likely 2023 will bring more of the s...